Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax Combined With BEAM in ASCT for DLBCL
NCT05863845Phase 2Unknown
- Sponsor
- Ruijin Hospital
- Start
- Jun 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of venetoclax in diffuse large B-cell lymphoma (DLBCL), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
venetoclax
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT05863845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05863845.